Cancer and fertility preservation: international recommendations from an expert meeting
暂无分享,去创建一个
Alberto Revelli | Mauro Costa | Claus Y. Andersen | F. Ubaldi | A. Partridge | W. Wallace | M. Lambertini | H. Azim | L. Del Mastro | F. Peccatori | A. Revelli | P. Anserini | Alessandra Gennari | Lucia Del Mastro | C. Andersen | H. Wallace | Filippo M. Ubaldi | A. Gennari | G. L. La Sala | Ann H. Partridge | Matteo Lambertini | Maria C. Pescio | Hatem A. Azim | Fedro A. Peccatori | Francesca Salvagno | Giovanni B. La Sala | Cristofaro De Stefano | W. Hamish Wallace | Paola Anserini | L. Mastro | F. Salvagno | M. Pescio | Mauro Costa | G. L. Sala | C. De Stefano | Cristofaro De Stefano
[1] A. Pellicer,et al. Obstetric outcome after oocyte vitrification and warming for fertility preservation in women with cancer. , 2014, Reproductive biomedicine online.
[2] T. Fornander,et al. Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial , 2009, Breast Cancer Research and Treatment.
[3] A. Loft,et al. Cryopreservation of ovarian tissue for a decade in Denmark: a view of the technique. , 2011, Reproductive biomedicine online.
[4] Satyaki Sengupta,et al. Chemotherapy-Induced Late Transgenerational Effects in Mice , 2011, PloS one.
[5] J. Raemaekers,et al. Premature ovarian failure and fertility in long-term survivors of Hodgkin's lymphoma: a European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d'Etude des Lymphomes de l'Adulte Cohort Study. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] A. Giwercman,et al. Risk of Birth Abnormalities in the Offspring of Men With a History of Cancer: A Cohort Study Using Danish and Swedish National Registries , 2011, Journal of the National Cancer Institute.
[7] M. Rezai,et al. Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] S. Kim,et al. Use of Hormonal Protection for Chemotherapy-induced Gonadotoxicity , 2010, Clinical obstetrics and gynecology.
[9] P. Patrizio,et al. Human oocyte cryopreservation with slow freezing versus vitrification. Results from the National Italian Registry data, 2007-2011. , 2014, Fertility and sterility.
[10] G. Hortobagyi,et al. Pregnancy and offspring after adjuvant chemotherapy in breast cancer patients , 1990, Cancer.
[11] Anna Carby,et al. Reproductive options for female cancer patients: balancing hope and realistic expectation , 2014, Current opinion in oncology.
[12] Amul Shah,et al. Results from the survey for preservation of adolescent reproduction (SPARE) study: gender disparity in delivery of fertility preservation message to adolescents with cancer , 2011, Journal of Assisted Reproduction and Genetics.
[13] N. Pavlidis,et al. Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies. , 2011, European journal of cancer.
[14] S. Fosså,et al. Paternity following treatment for testicular cancer. , 2005, Journal of the National Cancer Institute.
[15] C. Andersen,et al. The safety of transplanting cryopreserved ovarian tissue in cancer patients: a review of the literature , 2012, Journal of Assisted Reproduction and Genetics.
[16] H. Bang,et al. Age-specific probability of live birth with oocyte cryopreservation: an individual patient data meta-analysis. , 2013, Fertility and sterility.
[17] W. Wallace,et al. Predicting age of ovarian failure after radiation to a field that includes the ovaries. , 2005, International journal of radiation oncology, biology, physics.
[18] J. Pierce,et al. How do you feel about fertility and parenthood? The voices of young female cancer survivors , 2012, Journal of Cancer Survivorship.
[19] K. Oktay,et al. Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles. , 2011, Fertility and sterility.
[20] S. Willich,et al. Patient Counselling on the Risk of Infertility and Its Impact on Childhood Cancer Survivors: Results from a National Survey , 2011, Journal of psychosocial oncology.
[21] Y. Englert,et al. Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] N. Desai,et al. Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis. , 2010, Fertility and sterility.
[23] K. Oktay,et al. In vitro maturation of germinal vesicle oocytes recovered after premature luteinizing hormone surge: description of a novel approach to fertility preservation. , 2008, Fertility and sterility.
[24] W. Wallace,et al. Cancer treatment and gonadal function: experimental and established strategies for fertility preservation in children and young adults. , 2015, The lancet. Diabetes & endocrinology.
[25] S. Loh,et al. First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient. , 2014, Human reproduction.
[26] R. Rosenfeld. Patients , 2012, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[27] K. Oktay,et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] Li'na Hu,et al. Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal women. , 2011, The Cochrane database of systematic reviews.
[29] R. Tamimi,et al. Prospective study of fertility concerns and preservation strategies in young women with breast cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] Claus Yding Andersen,et al. Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. , 2013, Fertility and sterility.
[31] L. Fallowfield,et al. The OPTION trial of adjuvant ovarian protection by goserelin in adjuvant chemotherapy for early breast cancer. , 2010 .
[32] D. Merlo,et al. Is Letrozole needed for controlled ovarian stimulation in patients with estrogen receptor-positive breast cancer? , 2013, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[33] R. Farrell,et al. Protecting Ovaries During Chemotherapy Through Gonad Suppression: A Systematic Review and Meta-analysis. , 2015, Obstetrics and gynecology.
[34] M. Piccart,et al. Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] Zhixian Yuan,et al. Effect of leuprolide acetate on ovarian function after cyclophosphamide–doxorubicin-based chemotherapy in premenopausal patients with breast cancer: results from a phase II randomized trial , 2013, Medical Oncology.
[36] M. Cedars,et al. Effective method for emergency fertility preservation: random-start controlled ovarian stimulation. , 2012, Fertility and sterility.
[37] H. Gómez,et al. Attitudes of young patients with breast cancer toward fertility loss related to adjuvant systemic therapies. EORTC study 10002 BIG 3‐98 , 2014, Psycho-oncology.
[38] M. Beckmann,et al. Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation. , 2012, Fertility and sterility.
[39] T. Strowitzki,et al. Fertility preservation in >1,000 patients: patient’s characteristics, spectrum, efficacy and risks of applied preservation techniques , 2011, Archives of Gynecology and Obstetrics.
[40] John D Boice,et al. Congenital anomalies in the children of cancer survivors: a report from the childhood cancer survivor study. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[41] D. Meirow,et al. Luteal phase oocyte retrieval and in vitro maturation is an optional procedure for urgent fertility preservation. , 2011, Fertility and sterility.
[42] L. Brinton,et al. Long-term Relationship of Ovulation-Stimulating Drugs to Breast Cancer Risk , 2014, Cancer Epidemiology, Biomarkers & Prevention.
[43] W. Willett,et al. Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II , 2013, Breast Cancer Research.
[44] M. Beckmann,et al. Pregnancies and live births after 20 transplantations of cryopreserved ovarian tissue in a single center. , 2015, Fertility and Sterility.
[45] D. Lamb,et al. Cancer risk among children born after assisted conception. , 2014, The New England journal of medicine.
[46] F. V. van Leeuwen,et al. Autotransplantation of cryopreserved ovarian tissue in cancer survivors and the risk of reintroducing malignancy: a systematic review. , 2013, Human reproduction update.
[47] H. Critchley,et al. Impact of cancer treatment on uterine function. , 2005, Journal of the National Cancer Institute. Monographs.
[48] T. Tulandi,et al. Assisted reproductive outcomes of male cancer survivors , 2015, Journal of Cancer Survivorship.
[49] P. Katz,et al. Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer , 2012, Cancer.
[50] P. Patrizio,et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[51] W. Wallace,et al. The radiosensitivity of the human oocyte. , 2003, Human reproduction.
[52] M. Andersen,et al. Cryopreserved ovarian cortex from patients with leukemia in complete remission contains no apparent viable malignant cells. , 2012, Blood.
[53] L. Boni,et al. Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival: A Randomized Clinical Trial. , 2015, JAMA.
[54] D. Meirow,et al. Ovarian tissue cryopreservation and transplantation: a realistic, effective technology for fertility preservation. , 2014, Methods in molecular biology.
[55] G. Bedoschi,et al. Fertility Preservation Success Subsequent to Concurrent Aromatase Inhibitor Treatment and Ovarian Stimulation in Women With Breast Cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[56] S. Báo,et al. Effects of lowered temperatures and media on short-term preservation of zebu (Bos indicus) preantral ovarian follicles. , 2004, Theriogenology.
[57] E. Elgindy,et al. Protecting Ovaries During Chemotherapy Through Gonad Suppression: A Systematic Review and Meta-analysis , 2015, Obstetrics and gynecology.
[58] H. Yarali,et al. Best Protocol for Controlled Ovarian Hyperstimulation in Assisted Reproductive Technologies: Fact or Opinion? , 2014, Seminars in Reproductive Medicine.
[59] Yu Shyr,et al. Genetic disease in the children of Danish survivors of childhood and adolescent cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[60] D. Spiegelman,et al. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. , 2006, Journal of the National Cancer Institute.
[61] A. Veiga,et al. How does vitrification affect oocyte viability in oocyte donation cycles? A prospective study to compare outcomes achieved with fresh versus vitrified sibling oocytes. , 2013, Human reproduction.
[62] L. Schover,et al. The psychosocial impact of interrupted childbearing in long‐term female cancer survivors , 2012, Psycho-oncology.
[63] B. Pistilli,et al. Pregnancy following breast cancer using assisted reproduction and its effect on long-term outcome. , 2015, European journal of cancer.
[65] M. Höglund,et al. Sex differences in fertility-related information received by young adult cancer survivors. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[66] R. Chian,et al. Fertility Preservation with Immature and in Vitro Matured Oocytes , 2009, Seminars in reproductive medicine.
[67] R. Gelber,et al. Pregnancy after breast cancer: Are young patients willing to participate in clinical studies? , 2015, Breast.
[68] Xiao-yan Li,et al. Concurrent treatment with gonadotropin-releasing hormone agonists for chemotherapy-induced ovarian damage in premenopausal women with breast cancer: a meta-analysis of randomized controlled trials. , 2013, Breast.
[69] A. Agarwal,et al. Disruption of spermatogenesis by the cancer disease process. , 2005, Journal of the National Cancer Institute. Monographs.
[70] G. Bedoschi,et al. Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients. , 2013, Fertility and sterility.
[71] I. Ben-Aharon,et al. Doxorubicin-induced apoptosis in germinal vesicle (GV) oocytes. , 2010, Reproductive toxicology.
[72] S. Paluch-Shimon,et al. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies. , 2014, Fertility and sterility.
[73] M. van Wely,et al. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology. , 2014, The Cochrane database of systematic reviews.
[74] H. Bang,et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. , 2006, The Journal of clinical endocrinology and metabolism.
[75] A. Partridge,et al. Update on fertility preservation in young women undergoing breast cancer and ovarian cancer therapy , 2015, Current opinion in obstetrics & gynecology.
[76] P. Bruzzi,et al. Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials. , 2014, Cancer treatment reviews.
[77] S. Loibl,et al. Pregnancy occurring during or following adjuvant trastuzumab in patients enrolled in the HERA trial (BIG 01-01) , 2012, Breast Cancer Research and Treatment.
[78] R. Gelber,et al. Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.
[79] J. Donnez,et al. Transplantation of ovarian tissue. , 2014, Best practice & research. Clinical obstetrics & gynaecology.
[80] M. Alfò,et al. Impact of different treatment approaches on pregnancy outcomes in 99 women treated for Hodgkin lymphoma. , 2012, International journal of radiation oncology, biology, physics.
[81] D. Gook,et al. Human oocyte cryopreservation. , 2007, Human reproduction update.
[82] J. Forbes,et al. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. , 2015, The New England journal of medicine.
[83] Daniel H. Williams,et al. Sperm banking and the cancer patient , 2010, Therapeutic advances in urology.
[84] L. Kjeldsen,et al. Evidence of residual disease in cryopreserved ovarian cortex from female patients with leukemia. , 2010, Fertility and sterility.
[85] M. Sormani,et al. Breast cancer incidence after hormonal treatments for infertility: systematic review and meta-analysis of population-based studies , 2015, Breast Cancer Research and Treatment.
[86] J. Semmens,et al. Pregnancy after breast cancer: population based study , 2006, BMJ : British Medical Journal.
[87] M. El-ashry,et al. Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study. , 2009, Fertility and sterility.
[88] L. Rienzi,et al. Consistent and predictable delivery rates after oocyte vitrification: an observational longitudinal cohort multicentric study. , 2012, Human reproduction.
[89] L. Holmberg,et al. Birth Outcome in Women with Previously Treated Breast Cancer—A Population-Based Cohort Study from Sweden , 2006, PLoS medicine.
[90] G. Bedoschi,et al. Ovarian stimulation during the luteal phase for fertility preservation of cancer patients: case reports and review of the literature , 2010, Journal of Assisted Reproduction and Genetics.
[91] T. Fehm,et al. Pregnancy after Successful Cancer Treatment: What Needs to Be Considered? , 2012, Oncology Research and Treatment.
[92] Gary D. Smith,et al. Prospective randomized comparison of human oocyte cryopreservation with slow-rate freezing or vitrification. , 2010, Fertility and sterility.
[93] Lindsey M. King,et al. Discussion of fertility preservation with newly diagnosed patients: oncologists’ views , 2007, Journal of cancer survivorship : research and practice.
[94] G. Dohle. Male infertility in cancer patients: Review of the literature , 2010, International journal of urology : official journal of the Japanese Urological Association.
[95] C. Andersen. Success and challenges in fertility preservation after ovarian tissue grafting , 2015, The Lancet.
[96] L. Leibovici,et al. Pharmacological interventions for fertility preservation during chemotherapy: a systematic review and meta-analysis , 2010, Breast Cancer Research and Treatment.
[97] V. Diehl,et al. Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[98] C. Anders,et al. Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis. , 2009, Journal of women's health.
[99] H. Wasvary,et al. Multidisciplinary management of colorectal cancer enhances access to multimodal therapy and compliance with National Comprehensive Cancer Network (NCCN) guidelines , 2012, International Journal of Colorectal Disease.
[100] Y. Friedlander,et al. Cancer risk after exposure to treatments for ovulation induction. , 2008, American journal of epidemiology.
[101] R. Anderson,et al. Long term follow-up of survivors of childhood cancer: summary of updated SIGN guidance , 2013, BMJ.
[102] E. Winer,et al. Web-based survey of fertility issues in young women with breast cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[103] M. Chung,et al. Long-term ovarian function and fertility after heterotopic autotransplantation of cryobanked human ovarian tissue: 8-year experience in cancer patients. , 2009, Fertility and sterility.
[104] N. Pavlidis,et al. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[105] O. Khorshid,et al. Gonadatrophin Suppression to Prevent Chemotherapy-Induced Ovarian Damage: A Randomized Controlled Trial , 2013, Obstetrics and gynecology.
[106] A. Goldhirsch,et al. Timing of adjuvant systemic therapy and radiotherapy after breast-conserving surgery and mastectomy. , 2010, Cancer treatment reviews.
[107] K. Oktay,et al. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[108] M. Rosen,et al. Ovarian stimulation in cancer patients. , 2013, Fertility and sterility.
[109] F. Fu,et al. Gonadotropin-Releasing Hormone Analog Cotreatment for the Preservation of Ovarian Function during Gonadotoxic Chemotherapy for Breast Cancer: A Meta-Analysis , 2013, PloS one.
[110] T. Strowitzki,et al. Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. , 2009, Fertility and sterility.
[111] A. Rosen,et al. Psychosocial distress in young cancer survivors. , 2009, Seminars in oncology nursing.
[112] A. Veiga,et al. Live birth using vitrified--warmed oocytes in invasive ovarian cancer: case report and literature review. , 2014, Reproductive biomedicine online.
[113] L. Boni,et al. Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial. , 2011, JAMA.
[114] A. Pellicer,et al. Fertility preservation for age-related fertility decline , 2015, The Lancet.
[115] B. Källén,et al. Malignancies among women who gave birth after in vitro fertilization. , 2011, Human reproduction.
[116] S. Fosså,et al. Pregnancy after adolescent and adult cancer: A population‐based matched cohort study , 2011, International journal of cancer.
[117] S. Missmer,et al. Relationship between reproductive history, anthropometrics, lifestyle factors, and the likelihood of persistent chemotherapy-related amenorrhea in women with premenopausal breast cancer. , 2012, Fertility and sterility.
[118] A. Pellicer,et al. Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment. , 2012, Fertility and sterility.
[119] K. Oktay. Evidence for limiting ovarian tissue harvesting for the purpose of transplantation to women younger than 40 years of age. , 2002, The Journal of clinical endocrinology and metabolism.
[120] Kendra Johnson,et al. Integration of and adherence to National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines) in a Community Cancer Center , 2015 .
[121] P. Munster,et al. Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[122] K. Oktay,et al. Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[123] W. Wallace,et al. Fertility preservation for girls and young women with cancer: population-based validation of criteria for ovarian tissue cryopreservation , 2014, The Lancet. Oncology.
[124] D. Keefe,et al. Fertility in women with BRCA mutations: a case-control study. , 2010, Fertility and sterility.
[125] A. Loft,et al. Treatment history and outcome of 24 deliveries worldwide after autotransplantation of cryopreserved ovarian tissue, including two new Danish deliveries years after autotransplantation , 2014, Journal of Assisted Reproduction and Genetics.
[126] H. Kanety,et al. Cyclophosphamide Triggers Follicle Activation and “Burnout”; AS101 Prevents Follicle Loss and Preserves Fertility , 2013, Science Translational Medicine.
[127] Julian Peto,et al. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer , 1997, The Lancet.
[128] K. Diedrich,et al. Initiation of ovarian stimulation independent of the menstrual cycle: a case–control study , 2013, Archives of Gynecology and Obstetrics.
[129] U. Keskin,et al. Random-start controlled ovarian hyperstimulation with letrozole for fertility preservation in cancer patients: case series and review of literature. , 2014, JPMA. The Journal of the Pakistan Medical Association.
[130] T. Key,et al. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. , 2002, Journal of the National Cancer Institute.
[131] M. Hasanzadeh,et al. Ovarian preservation with gonadotropin‐releasing hormone analog during chemotherapy , 2007 .
[132] V. Diehl,et al. No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study Group. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[133] Richard A. Anderson,et al. Fertility preservation for young patients with cancer: who is at risk and what can be offered? , 2005, The Lancet. Oncology.
[134] F. Amant,et al. Strategies for fertility preservation in young early breast cancer patients. , 2014, Breast.
[135] B. Kong,et al. Protection of ovarian function by GnRH agonists during chemotherapy: a meta-analysis. , 2014, International journal of oncology.
[136] S. Loibl,et al. Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.
[137] N. Michaan,et al. Ovarian stimulation and emergency in vitro fertilization for fertility preservation in cancer patients. , 2010, European journal of obstetrics, gynecology, and reproductive biology.
[138] W. Wallace,et al. Safety considerations for transplanting cryopreserved ovarian tissue to restore fertility in female patients who have recovered from Ewing's sarcoma. , 2014, Future oncology.
[139] Z. Rosenwaks,et al. Successful treatment of postchemotherapy azoospermia with microsurgical testicular sperm extraction: the Weill Cornell experience. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[140] S. Nayak,et al. Random-start gonadotropin-releasing hormone (GnRH) antagonist-treated cycles with GnRH agonist trigger for fertility preservation. , 2011, Fertility and sterility.
[141] K. Rothman,et al. Birth outcome in women with breast cancer , 2005, British Journal of Cancer.
[142] L. Westphal,et al. Ovarian stimulation for fertility preservation in patients with cancer. , 2010, Fertility and sterility.
[143] P. Patrizio,et al. Sperm cryopreservation for male patients with cancer: an epidemiological analysis at the University of Pennsylvania. , 2003, European journal of obstetrics, gynecology, and reproductive biology.
[144] S. Tough,et al. Delayed child-bearing. , 2012, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.
[145] M. Clark,et al. Discussions regarding reproductive health for young women with breast cancer undergoing chemotherapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[146] Peng Li,et al. Fertility outcome of patients with testicular tumor: Before and after treatment , 2013, Asian journal of andrology.
[147] A. Nyboe Andersen,et al. Survival of primordial follicles following prolonged transportation of ovarian tissue prior to cryopreservation. , 2003, Human reproduction.
[148] C. Fung,et al. Gonadotropin-releasing hormone agonists for the preservation of ovarian function among women with breast cancer who did not use tamoxifen after chemotherapy: a systematic review and meta-analysis. , 2014, Fertility and sterility.
[149] E. Porcu,et al. Multicenter observational study on slow-cooling oocyte cryopreservation: clinical outcome. , 2010, Fertility and sterility.
[150] A. Ciapponi,et al. Vitrification versus slow freezing for women undergoing oocyte cryopreservation. , 2014, The Cochrane database of systematic reviews.
[151] A. Borini,et al. Oocyte slow freezing using a 0.2-0.3 M sucrose concentration protocol: is it really the time to trash the cryopreservation machine? , 2012, Fertility and sterility.
[152] E. Ernst,et al. Long-term duration of function of ovarian tissue transplants: case reports. , 2012, Reproductive biomedicine online.